4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-17-000099
Director bought 2,130 shares at $6.51 ($13,866)
- Director acquired 124 shares (code L)
- Director acquired 20,227 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eberwein Jeffrey E. Director | 2017-01-20 | Other acquisition | +124 | $6.51 | $807 | 80,057 | I |
| Eberwein Jeffrey E. Director | 2017-01-23 | Purchase | +2,130 | $6.51 | $13,866 | 82,187 | I |
| Eberwein Jeffrey E. Director | 2017-01-24 | Option exercise | +20,227 | 20,227 | D | ||
| Derivatives | |||||||
| Eberwein Jeffrey E. Director | 2017-01-24 | Option exercise · Restricted Stock Unit | +20,227 | 0 | D | ||
| Open-market purchases · 2,130 sh · avg $6.51 · $13,866 | |||||||
Loading xslF345X03/form410211002_01252017.xml…